Information Provided By: 
Fly News Breaks for March 5, 2020
SPLK
Mar 5, 2020 | 07:57 EDT
Oppenheimer analyst Shaul Eyal raised the firm's price target on Splunk to $170 from $154 and keeps an Outperform rating on the shares. The analyst cited "solid" Q4 results, while noting that "strong demand" for Splunk solutions is somewhat masked by the transition to a ratable model.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
